[{"Assets_0_Q2_USD":210671000.0,"CommonStockSharesOutstanding_0_Q2_shares":44845853.0,"NetIncomeLoss_2_Q2_USD":-9179000.0,"NetIncomeLoss_1_Q2_USD":-1534000.0,"StockholdersEquity_0_Q2_USD":131418000.0,"Ticker":"VNDA","CIK":"1347178","name":"VANDA PHARMACEUTICALS INC.","OfficialName":"Vanda Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"633424667.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170803"}]